Welsh Government

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

A modern passenger train at a railway station in Wales, reflecting the UK Government’s commitment to new stations and long-term rail investment across the Welsh rail network.

Seven new stations mark start of long-term Welsh rail reset backed by UK Government

UK Government endorses Transport for Wales rail vision, confirming seven new stations, major funding, and long-term infrastructure delivery across Wales.

bySrinath

February 18, 2026

Representative image of Welsh rail infrastructure investment and regional economic development

UK Spending Review 2025: £445m rail pledge and £22.4bn settlement set stage for Welsh economic reset

Explore how the UK’s £445M rail pledge and £22.4B Welsh settlement are poised to transform transport, industry, and growth across Wales.

byPallavi Madhiraju

June 12, 2025

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Seven new stations mark start of long-term Welsh rail reset backed by UK Government

UK Spending Review 2025: £445m rail pledge and £22.4bn settlement set stage for Welsh economic reset

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

SAMILBIO expands Chaeyun skincare with two November launches as K-beauty exports reach $11.1bn

Schneider Electric Infrastructure (SCHNEIDER) shares fall 3.5% despite new factory expansion: What will November results reveal?

Haleon (HLN) near 319p: Does a 15% share-price crash make its valuation attractive after the growth downgrade?

Ethan Allen will split CEO and chair roles, but who gets to choose Farooq Kathwari’s successor?